Pdp 200 mg (200 mg Spl)
Rubraca Tablet, Film Coated
Product Images NDC 82154-0784
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rubraca (NDC 82154-0784). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pharmaand Gmbh, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Pdp 250 mg (250 mg Spl)
This text provides information about the usual dosage and storage instructions for a certain product. It mentions that the prescribing information should be consulted for dosage details. The storage temperature should be between 20°C and 25°C (68°F and 77°F), with excursions allowed between 15°C and 30°C (59°F and 86°F). The product is distributed by 2r pharmat GmbH, located at Taborstrasse 1, 1020 Vienna, Austria. It is made in Switzerland. Each tablet or tab contains 430 mg of rucaparb camsylate, which is equivalent to 250 mg of xeperk. The product is labeled with the code 2154-0784-1 and contains 60 tablets. It is only available with a prescription and should be kept out of reach of children.*
Pdp 300 mg (300 mg Spl)
Structural Formula (Rub01 0018 01)
Figure 1 (Rub01 0018 02)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
